Ovarian Cancer Trial, Recruiting NCT06781151 Sponsor: Sun Yat-sen University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06781151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with ovarian, cervical, or endometrial cancer that has come back after previous treatment, and a specialist has referred you for a team-based medical consultation
  • You have at least one area of cancer in your body that doctors can measure or evaluate
  • You are willing to take part in a consultation involving a team of different medical specialists
  • You are 18 years of age or older
  • You have enough tumor tissue available from a previous biopsy or surgery for specialized genetic testing, with a sufficient amount of cancer cells present in the sample (confirm with trial site)
  • You are able and willing to give your informed consent, meaning you understand what the study involves and agree to take part

Who may not be able to join:

  • You currently have more than one type of cancer at the same time
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jihong Liu, PhD, Sun Yat'sen University Cancer Center

Phone: 15017599965

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 April 2024
Est. completion
18 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the overall response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov